Clinicians must consider patient comorbidities and therapy safety when selecting immunotherapy for cSCC, says Todd ...

Markets rebounded after President Trump's comments suggested the Iran conflict could be near an end, easing investor fears after days of declines. Oil prices surged on supply fears, then plunged after ...

Novo Nordisk A/S remains a Buy despite CagriSema setback; Eli Lilly and Company remains a Hold on valuation. Click for this ...

With various challenges impacting the clinical supply chain, existing models are no longer fit-for-purpose and need to adapt.

Artificial Intelligence (AI) is often discussed in broad terms, with promises of transformation at scale. In practice, however, its value is realized in far more specific ways – when it is applied to ...

Ireland’s biopharmaceutical sector continues to thrive amid key financial incentives, proximity to key markets, and favorable regulatory frameworks.

Agency staff "strongly recommended" a sham surgery-controlled trial be conducted before an approval filing, a stance one analyst called a "worst case scenario" for UniQure.

Generate:Biomedicines has hit the public markets as the world begins to question the usefulness of AI technology. CEO Mike Nally says biology is the key to unlocking the technology’s full potential.

Since the start of the millennium, podcasts have gone from nonexistent to numbering in the millions, and Edison Research ...

Novartis has settled a lawsuit by the estate of Henrietta Lacks that alleged the pharmaceutical giant unjustly profited off her cells, which were taken from her tumor without her knowledge in 1951 and ...

The annual event aims to raise awareness about rare diseases through education, collaboration and community engagement.

In one corner: consumers fed up with high drug prices. In the other: pharmaceutical companies arguing that price controls stifle innovation. The still-resonant 2003 documentary 'The Other Drug War' is ...